Divalproex Sodium Delayed Release Tablets USP, 500 mg, 100-count bottle, RX Only, Manufactured by...

FDA Drug Recall #D-0228-2018 — Class II — December 19, 2017

Recall Summary

Recall Number D-0228-2018
Classification Class II — Moderate risk
Date Initiated December 19, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Unichem Pharmaceuticals Usa Inc
Location Hasbrouck Heights, NJ
Product Type Drugs
Quantity 96,876 Bottles of 30s

Product Description

Divalproex Sodium Delayed Release Tablets USP, 500 mg, 100-count bottle, RX Only, Manufactured by: Unichem Laboratories Ltd. Ind. Area, Meerut Road, Ghaziabad-201 003, India. Marketed By: Unichem Pharmaceuticals (USA), Inc. Hasbrouck Heights, NJ 07604. NDC 29300-140-01

Reason for Recall

Cross Contamination With Other Products: metronidazole powder was found in one bottle of Divalproex Sodium.

Distribution Pattern

Product was distributed nationwide in the USA.

Lot / Code Information

Lot: ZDPH17040

Other Recalls from Unichem Pharmaceuticals Usa Inc

Recall # Classification Product Date
D-1541-2022 Class III Clonidine Hydrochloride Tablets, USP, 0.3 mg, 1... Sep 19, 2022
D-0255-2022 Class III Topiramate Tablets, USP 50 mg, 500-count bottle... Oct 25, 2021
D-1291-2020 Class III Clonidine Hydrochloride Tablets, USP 0.1 mg 100... May 26, 2020
D-0829-2020 Class III Clonidine Hydrochloride Tablets, USP 0.1mg, Rx ... Jan 29, 2020
D-0010-2018 Class II Bisoprolol Fumarate tablets, 5 mg, 30-count b... Oct 2, 2017

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.